Safety, Tolerability, and Efficacy of MatriPlax in Subjects With Acute Respiratory Distress Syndrome
Clinical trial NCT05886985 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05886985
- Sponsor
- BioSpring Medical Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.